Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS Trial)

NCT02603406 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT02603406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02603406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS Trial)
Lead sponsor
Ajou University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
July 15, 2016
Completion date
December 31, 2019
Enrollment
44 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

angiogenesis, ischemic stroke